Ember vs Infinitus

The two meet in a provider's dealings with payers. Infinitus agents phone payers to gather benefits and prior authorization status, and the vendor also serves pharma, naming Amgen and Pfizer on its homepage. Ember's appeal engine reads CARC and RARC codes, drafts the appeal letter and tracks the claim through adjudication, its coding engine reviews encounters with a rule citation on each flag, and its seed announcement adds a payer compliance check before submission.

A ModMed practice with a denial backlog finds its tools in that list. Infinitus's homepage describes benefit and prior authorization status calls, which answer a different bottleneck.

Ember lists athenahealth and ModMed among its EHR logos and reported a $4.3M seed in November 2025, led by Nexus Venture Partners. Infinitus raised a $51.5M Series C in October 2024, led by Andreessen Horowitz. The October 2024 release says $102.9M in total, and Crunchbase lists $51.4M.

A pharma support program that needs benefit and prior authorization calls placed goes to Infinitus, and a practice reading denial codes goes to Ember.